Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387357928> ?p ?o ?g. }
- W4387357928 abstract "Abstract Background Pituitary pars intermedia dysfunction (PPID) is a prevalent, age‐related chronic disorder in equids. Diagnosis of PPID can be challenging because of its broad spectrum of clinical presentations and disparate published diagnostic criteria, and there are limited available treatment options. Objectives To develop evidence‐based primary care guidelines for the diagnosis and treatment of equine PPID based on the available literature. Study design Evidence‐based clinical guideline using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. Methods Research questions were proposed by a panel of veterinarians and developed into PICO or another structured format. VetSRev and Veterinary Evidence were searched for evidence summaries, and systematic searches of the NCBI PubMed and CAB Direct databases were conducted using keyword searches in July 2022 and updated in January 2023. The evidence was evaluated using the GRADE framework. Results and recommendations The research questions were categorised into four areas: (A) Case selection for diagnostic testing, pre‐test probability and diagnostic test accuracy, (B) interpretation of test results, (C) pharmacological treatments and other treatment/management options and (D) monitoring treated cases. Relevant veterinary publications were identified and assessed using the GRADE criteria. The results were developed into recommendations: (A) Case selection for diagnostic testing and diagnostic test accuracy: (i) The prevalence of PPID in equids aged ≥15 years is between 21% and 27%; (ii) hypertrichosis or delayed/incomplete hair coat shedding provides a high index of clinical suspicion for PPID; (iii) the combination of clinical signs and age informs the index of clinical suspicion prior to diagnostic testing; (iv) estimated pre‐test probability of PPID should be considered in interpretation of diagnostic test results; (v) pre‐test probability of PPID is low in equids aged <10 years; (vi) both pre‐test probability of disease and season of testing have strong influence on the ability to diagnose PPID using basal adrenocorticotropic hormone (ACTH) or ACTH after thyrotropin‐releasing hormone (TRH) stimulation. The overall diagnostic accuracy of basal ACTH concentrations for diagnosing PPID ranged between 88% and 92% in the autumn and 70% and 86% in the non‐autumn, depending on the pre‐test probability. Based on a single study, the overall diagnostic accuracy of ACTH concentrations in response to TRH after 30 minutes for diagnosing PPID ranged between 92% and 98% in the autumn and 90% and 94% in the non‐autumn, depending on the pre‐test probability. Thus, it should be remembered that the risk of a false positive result increases in situations where there is a low pre‐test probability, which could mean that treatment is initiated for PPID without checking for a more likely alternative diagnosis. This could compromise horse welfare due to the commencement of lifelong therapy and/or failing to identify and treat an alternative potentially life‐threatening condition. (B) Interpretation of diagnostic tests: (i) There is a significant effect of breed on plasma ACTH concentration, particularly in the autumn with markedly higher ACTH concentrations in some but not all ‘thrifty’ breeds; (ii) basal and/or post‐TRH ACTH concentrations may also be affected by latitude/location, diet/feeding, coat colour, critical illness and trailer transport; (iii) mild pain is unlikely to have a large effect on basal ACTH, but caution may be required for more severe pain; (iv) determining diagnostic thresholds that allow for all possible contributory factors is not practical; therefore, the use of equivocal ranges is supported; (v) dynamic insulin testing and TRH stimulation testing may be combined, but TRH stimulation testing should not immediately follow an oral sugar test; (vi) equids with PPID and hyperinsulinaemia appear to be at higher risk of laminitis, but ACTH is not an independent predictor of laminitis risk. (C) Pharmacologic treatments and other treatment/management options: (i) Pergolide improves most clinical signs associated with PPID in the majority of affected animals; (ii) Pergolide treatment lowers basal ACTH concentrations and improves the ACTH response to TRH in many animals, but measures of insulin dysregulation (ID) are not altered in most cases; (iii) chasteberry has no effect on ACTH concentrations and there is no benefit to adding chasteberry to pergolide therapy; (iv) combination of cyproheptadine with pergolide is not superior to pergolide alone; (v) there is no evidence that pergolide has adverse cardiac effects in horses; (vi) Pergolide does not affect insulin sensitivity. (D) Monitoring pergolide‐treated cases: (i) Hormone assays provide a crude indication of pituitary control in response to pergolide therapy, however it is unknown whether monitoring of ACTH concentrations and titrating of pergolide doses accordingly is associated with improved endocrinological or clinical outcome; (ii) it is unknown whether monitoring the ACTH response to TRH or clinical signs is associated with an improved outcome; (iii) there is very weak evidence to suggest that increasing pergolide dose in autumn months may be beneficial; (iv) there is little advantage in waiting for more than a month to perform follow‐up endocrine testing following initiation of pergolide therapy; there may be merit in performing repeat tests sooner; (v) timing of sampling in relation to pergolide dosing does not confound measurement of ACTH concentration; (vi) there is no evidence that making changes after interpretation of ACTH concentrations measured at certain times of the year is associated with improved outcomes; (vii) evidence is very limited, however, compliance with PPID treatment appears to be poor and it is unclear whether this influences clinical outcome; (viii) evidence is very limited, but horses with clinical signs of PPID are likely to shed more nematode eggs than horses without clinical signs of PPID; it is unclear whether this results in an increased risk of parasitic disease or whether there is a need for more frequent assessment of faecal worm egg counts. Main limitations Limited relevant publications in the veterinary scientific literature. Conclusions These findings should be used to inform decision‐making in equine primary care practice." @default.
- W4387357928 created "2023-10-06" @default.
- W4387357928 creator A5017962357 @default.
- W4387357928 creator A5023690050 @default.
- W4387357928 creator A5029618532 @default.
- W4387357928 creator A5047759812 @default.
- W4387357928 creator A5048186195 @default.
- W4387357928 creator A5051183493 @default.
- W4387357928 creator A5056781573 @default.
- W4387357928 creator A5067020262 @default.
- W4387357928 date "2023-10-05" @default.
- W4387357928 modified "2023-10-17" @default.
- W4387357928 title "BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction" @default.
- W4387357928 cites W1572905097 @default.
- W4387357928 cites W1586150751 @default.
- W4387357928 cites W1622233041 @default.
- W4387357928 cites W1893550040 @default.
- W4387357928 cites W1927795031 @default.
- W4387357928 cites W1966621878 @default.
- W4387357928 cites W1975625393 @default.
- W4387357928 cites W1981960081 @default.
- W4387357928 cites W1992720026 @default.
- W4387357928 cites W1995814508 @default.
- W4387357928 cites W2005825739 @default.
- W4387357928 cites W2010149513 @default.
- W4387357928 cites W2015726993 @default.
- W4387357928 cites W2033293578 @default.
- W4387357928 cites W2034577015 @default.
- W4387357928 cites W2047186143 @default.
- W4387357928 cites W2047244230 @default.
- W4387357928 cites W2048114721 @default.
- W4387357928 cites W2050365411 @default.
- W4387357928 cites W2053426730 @default.
- W4387357928 cites W2061959181 @default.
- W4387357928 cites W2074439478 @default.
- W4387357928 cites W2076110869 @default.
- W4387357928 cites W2100110005 @default.
- W4387357928 cites W2102824363 @default.
- W4387357928 cites W2104323448 @default.
- W4387357928 cites W2104535495 @default.
- W4387357928 cites W2104675861 @default.
- W4387357928 cites W2104833543 @default.
- W4387357928 cites W2110030122 @default.
- W4387357928 cites W2115859831 @default.
- W4387357928 cites W2117660344 @default.
- W4387357928 cites W2130637826 @default.
- W4387357928 cites W2132864892 @default.
- W4387357928 cites W2138578607 @default.
- W4387357928 cites W2148556379 @default.
- W4387357928 cites W2148915117 @default.
- W4387357928 cites W2160621958 @default.
- W4387357928 cites W2223149604 @default.
- W4387357928 cites W2229831273 @default.
- W4387357928 cites W2428702349 @default.
- W4387357928 cites W2465537805 @default.
- W4387357928 cites W2501959588 @default.
- W4387357928 cites W2511923395 @default.
- W4387357928 cites W2551730106 @default.
- W4387357928 cites W2616950929 @default.
- W4387357928 cites W2728616999 @default.
- W4387357928 cites W2765357612 @default.
- W4387357928 cites W2769473742 @default.
- W4387357928 cites W2789236479 @default.
- W4387357928 cites W2791251076 @default.
- W4387357928 cites W2803545031 @default.
- W4387357928 cites W2883723527 @default.
- W4387357928 cites W2895857412 @default.
- W4387357928 cites W2901658223 @default.
- W4387357928 cites W2911265402 @default.
- W4387357928 cites W2913831394 @default.
- W4387357928 cites W2940054686 @default.
- W4387357928 cites W2969420082 @default.
- W4387357928 cites W2973084332 @default.
- W4387357928 cites W2973154059 @default.
- W4387357928 cites W2982499691 @default.
- W4387357928 cites W3029448977 @default.
- W4387357928 cites W3032099282 @default.
- W4387357928 cites W3046002897 @default.
- W4387357928 cites W3049101316 @default.
- W4387357928 cites W3091245521 @default.
- W4387357928 cites W3091858560 @default.
- W4387357928 cites W3108255996 @default.
- W4387357928 cites W3117958629 @default.
- W4387357928 cites W3133125729 @default.
- W4387357928 cites W3163979140 @default.
- W4387357928 cites W3164619582 @default.
- W4387357928 cites W3187661731 @default.
- W4387357928 cites W3195093458 @default.
- W4387357928 cites W3206624161 @default.
- W4387357928 cites W3211487790 @default.
- W4387357928 cites W3215557731 @default.
- W4387357928 cites W4210556574 @default.
- W4387357928 cites W4220698972 @default.
- W4387357928 cites W4225105009 @default.
- W4387357928 cites W4283821926 @default.
- W4387357928 cites W4297183080 @default.
- W4387357928 cites W4298058444 @default.
- W4387357928 cites W4306762147 @default.
- W4387357928 cites W658127536 @default.
- W4387357928 doi "https://doi.org/10.1111/evj.14009" @default.